A rating of 58 puts Gain Therapeutics Inc (GANX) near the middle of the Biotechnology industry according to InvestorsObserver. Gain Therapeutics Inc's score of 58 means it scores higher than 58% of stocks in the industry. Gain Therapeutics Inc also received an overall rating of 47, putting it above 47% of all stocks. Biotechnology is ranked 53 out of the 148 industries.
GANX has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on GANX!